Patent · US Active

TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof

US10907138B2 · kind B2 · utility

0Cited by

2References

16Claims

0Family size

Assignee

ALMA MATER STUDIORUM—UNIVERSITÀ DI BOLOGNA · IT

Inventors

Elisabetta Ciani · Bologna, IT
Franco Laccone · Stockerau, AT

Key dates

Filing date	Mar 6, 2020
Grant date	Feb 2, 2021
Priority date	—
Expiry date	Mar 6, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y207/11022
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compositions and formulations containing a TATk-CDKL5 fusion protein. Also disclosed are methods of producing a TATk-CDKL5 fusion protein from vectors containing a TATk-CDKL5 cDNA and methods of transducing cells with the vectors containing a TATk-CDKL5 cDNA and the TATk-CDKL5 fusion protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.